(function(){var loadHandler=window['sl_{D0ADD9BC-5BCE-4B01-85F9-188A7AEC90E6}'];loadHandler&&loadHandler(128, '<div id="spr0_aef6d9a"><div id="spr1_aef6d9a" class="kern slide"><img id="img2_aef6d9a" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_aef6d9a" class="kern slide"><div id="spr3_aef6d9a" style="left:119.79px;top:205.267px;"><img id="img0_aef6d9a" src="data/img154.png" width="521.25" height="288" alt=""/></div><div id="spr4_aef6d9a" style="left:22.236px;top:65.636px;"><img id="img1_aef6d9a" src="data/img155.png" width="491.25" height="139.5" alt="" style="left:-0.009px;top:0.049px;"/></div><div id="spr5_aef6d9a" style="top:6.64px;"><div style="width:0px;"><span id="txt0_aef6d9a" data-width="437.027344" style="left:28.339px;top:0.564px;">MONARCH2: Fulvestrant + CDK4/6-inhibitors</span></div><div style="width:0px;"><span id="txt1_aef6d9a" data-width="156.011719" style="left:168.089px;top:29.364px;">is even better …</span></div></div><div id="spr6_aef6d9a" style="left:29.517px;top:205.267px;"><div style="width:0px;"><span id="txt2_aef6d9a" class="nokern relpos" data-width="26.834473" style="left:7.2px;top:4.133px;">JCO: </span><span id="txt3_aef6d9a" class="nokern relpos" data-width="62.456543" style="left:7.195px;top:4.133px;">June 3, 2017</span></div></div><div id="svg7_aef6d9a" style="left:37.947px;top:222.746px;"><svg width="41" height="55" viewBox="-1.76 -1.67 41 55"><g fill="none"><g transform="translate(1.239582,0.84465)"><g fill="#ff0000" stroke="none" transform="translate(-1.239583,-0.844654)"><path stroke="#ff0000" stroke-width="3" stroke-linecap="butt" transform="translate(1.239583,0.844654)" d="M0,49.467 L29.181,6.642"/><path transform="matrix(0.563102,-0.826387,0.826387,0.563102,1.239581,50.31142)" d="M59.859,0 L50.929,4.465 V-4.465 Z"/></g></g></g></svg></div><div id="spr7_aef6d9a" style="left:133.797px;top:487.315px;"><div style="width:0px;"><span id="txt4_aef6d9a" class="relpos" data-width="206.578125" style="left:16.62px;top:1.576px;">Advanced ER+ve breast cancer, </span><span id="txt5_aef6d9a" class="relpos" data-width="256.937500" style="left:16.615px;top:1.576px;">resistant to previous endocrine therapy</span></div><div style="width:0px;"><span id="txt6_aef6d9a" class="relpos" data-width="321.359375" style="left:13.855px;top:20.776px;">(we will discuss endocrine resistance during the 2</span><span id="txt7_aef6d9a" class="relpos" data-width="11.208334" style="left:13.85px;top:21.643px;">nd</span><span id="txt8_aef6d9a" class="relpos" data-width="133.695313" style="left:13.845px;top:20.776px;"> part of the seminar)</span></div></div><div id="spr8_aef6d9a" style="left:571.424px;top:99.674px;"><div style="width:0px;"><span id="txt9_aef6d9a" data-width="96.960938" style="left:13.918px;top:1.323px;">A paper from</span></div><div style="width:0px;"><span id="txt10_aef6d9a" data-width="109.283203" style="left:7.803px;top:22.923px;">the reading list</span></div></div></div></div>');})();